Holmusk, a trailblazer in the field of data analytics and health technology, recently announced a significant funding milestone, successfully raising $45 million. This injection of capital will be instrumental in furthering Holmusk’s mission to harness real-world evidence to transform both research and care in the behavioral health arena. Established in 2015 and with dual headquarters in Singapore and New York, Holmusk is at the forefront of innovation, combining a leading behavioral health database with AI-powered analytics and digital solutions tailored to address the most pressing challenges faced in the sector. With its flagship offerings, such as the HolCare EHR+ platform which integrates measurement-based care directly into electronic health records, and NeuroBlu Research, a cutting-edge data analytics tool designed to enable deeper explorations of patient cohorts and datasets, Holmusk is redefining how behavioral health data is utilized. This recent funding will not only bolster the development of these groundbreaking solutions but also expand their reach to improve patient outcomes on a global scale. Recognized as a Technology Pioneer by the World Economic Forum in 2019, Holmusk is poised for transformative growth as it continues to innovate and bridge gaps in behavioral health research and care. The company’s commitment to using data for the greater good has never been more relevant, and with this new funding, Holmusk is all set to lead the charge in shaping the future of mental health care.

Health Tech Innovator Holmusk Secures $45M in Series B Funding
Get the full Holmusk company profile
Access contacts, investors, buying signals & more
Other recently funded companies
View all
Centricity WealthTech
Founded in January 2022, Centricity helps empower finance and investment professionals aspiring to establish their independent practices. The platform aims to deliver a comprehensive SAAS based investment management platform including digital transactional capabilities for a diversified product suite. Wealth management professionals prefer focusing on their clients’ interests and not their employers ever-changing priorities. Also, clients want stability and not a relentless institutional product push. We are looking to bring in consistency of the family office experience for a spectrum of investors across emerging affluent, affluent and high net worth categories. We are boutique by design and an institution by default.
$30.0M Series a
today

MigmaAI
Create, design and send on-brand emails in seconds.
$330.0K Pre-seed
today

Multiverse
Multiverse is the upskilling platform for AI and tech adoption. We’ve built a new model for transforming today’s workforce by combining expert human coaching with AI. Our learning drives real business impact and helps organisations close critical skills gaps - especially in data, AI and all things tech. We’ve already partnered with over 1,500 global organisations to transform their workforce through tech skills. Trusted by Microsoft, Mars, John Lewis Partnership and many more to upskill their team and unlock people’s potential and output. In 2022, we raised our $220m Series D funding - one of the largest venture rounds in EdTech history. We’re proud to be backed by some of the world’s biggest investors, including General Catalyst, Lightspeed Venture Partners and StepStone Group.
$70.0M Unknown
today

SWELL Sculpture Festival
SWELL Sculpture Festival (SWELL) is a multifaceted arts organisation that connects people, art, and place, based in Currumbin, Gold Coast, Queensland. Since 2003 SWELL has exhibited 873 Sculptures in the main exhibition on Currumbin Beach with a portfolio value worth $15.5M.
$5.5K Grant
today

Parcel Health
Healthcare and pharmacies' supply chain runs on expensive plastic. Billions of units of disposable, single-use supplies and packaging — most of it never questioned, never redesigned, never replaced. Paid for at a premium to budgets and to the environment. Until now. Parcel Health is reimagining healthcare supplies, creating products that can protect people and preserve the planet, all at an affordable price point. Tully Tube® is the world's first and only paper pill bottle that meets U.S. regulatory requirements. It is trusted by leading hospital health-systems like Dartmouth-Hitchcock Health System, Allegheny Health Network, and Wellstar Health System. This is just the beginning. Parcel Health is building a future where healthcare supplies are safer for patients, better for the planet, and easier on budgets.
$1.2M Seed
today
Other recent Series b rounds
Companies that recently closed a Series b round.
| # | Company | Round | Amount | Date |
|---|---|---|---|---|
| 1 | ![]() equipifi United States | Series b | $34.0M | today |
| 2 | ![]() ANELLO Photonics United States | Series b | $25.0M | 1d ago |
| 3 | ![]() Forest United States | Series b | $23.0M | 1d ago |
| 4 | ![]() EnteroBiotix United Kingdom | Series b | $23.9M | 1d ago |
| 5 | ![]() Fractile United Kingdom | Series b | $220.0M | 1d ago |




